![]() ![]() ![]() Explain what the patient should do if they forget a dose.Explain the different types of warfarin tablets.Explain that warfarin should be taken at the same time each day.Explain what the patient’s target INR range is.Explain that the action of warfarin can be reversed with an antidote if needed.Explain what warfarin can be used to treat.Explain that warfarin works by thinning the blood.Explore what the patient is hoping to get out of the consultation.Ask if the patient has any concerns about warfarin. ![]() Explore what the patient currently understands about warfarin and why they are being prescribed it.Explain the reason for the consultation.Confirm the patient’s name and date of birth.Introduce yourself to the patient including your name and role.Wash your hands and don PPE if appropriate.Left ventricular ejection fractionMitral, tricuspid or pulmonary position.**Patient-related risk factors for thrombosis: High: Starr-Edwards, Omniscience, Lillehei-Kaster.Medium: Bjork-Shiley, other bileaflet valves.Low: Carbomedics (aortic position), Medtronic Hall, St Jude Medical (without silzone).Mitral or Tricuspid Valve Replacement, or Target INR range based on indications Target INR in mechanical heart valve replacement Mechanical Prosthesis thrombogenicity* To minimize cardioversion cancellations due to low INRs on the day of the procedure we recommend a target INR of 3.0 prior to the procedure and 2.5 afterward (Oxford guidelines). Warfarin is not usually indicated for ischaemic stroke without atrial fibrillation (except in antiphospholipid syndrome), retinal vessel occlusion, peripheral artery thrombosis, coronary artery graft or coronary angioplasty, and stents.Īnticoagulation for 4 weeks before and for 3 months afterward. *The 2016 European Society of Cardiology (ESC) guidelines on cardioversion state that patients who have been in AF for longer than 48 hours should start OAC therapy at least 3 weeks before cardioversion and continue for 4 weeks afterwards (in those without a need for long-term anticoagulation).Ītrial fibrillation Anticoagulation is normally offered to patients with a CHADSVASc score ≥ 2 and considered in men with a CHADSVASc score of 1. Others are: Recurrent VTE (DVT or PE) despite adequate anticoagulation any changes in the patient’s clinical condition.Before adjusting the dose of warfarin the physician should review: ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |